Does ABEMACICLIB Cause Second primary malignancy? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Second primary malignancy have been filed in association with ABEMACICLIB (Verzenio). This represents 0.1% of all adverse event reports for ABEMACICLIB.
12
Reports of Second primary malignancy with ABEMACICLIB
0.1%
of all ABEMACICLIB reports
3
Deaths
8
Hospitalizations
How Dangerous Is Second primary malignancy From ABEMACICLIB?
Of the 12 reports, 3 (25.0%) resulted in death, 8 (66.7%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABEMACICLIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does ABEMACICLIB Cause?
Diarrhoea (4,988)
Fatigue (1,878)
Nausea (1,682)
Vomiting (943)
Malignant neoplasm progression (890)
Decreased appetite (744)
Death (696)
Asthenia (678)
Drug ineffective (668)
White blood cell count decreased (566)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which ABEMACICLIB Alternatives Have Lower Second primary malignancy Risk?
ABEMACICLIB vs ABILIFY
ABEMACICLIB vs ABIRATERONE
ABEMACICLIB vs ABIRATERONE\ABIRATERONE
ABEMACICLIB vs ABOBOTULINUMTOXINA
ABEMACICLIB vs ABRAXANE